AVENUE THERAPEUTICS, INC. Net Income (Loss) Available to Common Stockholders, Basic
AVENUE THERAPEUTICS, INC. (ATXI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$690.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-07
- AVENUE THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$690.00K, a 305.97% decline year-over-year.
- AVENUE THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$683.00K.
- AVENUE THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was $335.00K.
- AVENUE THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-12-31 was $7.27M, a 1035.31% increase year-over-year.
- AVENUE THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$11.65M.
- AVENUE THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$10.38M.
- AVENUE THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$3.55M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 5 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$690.00K 10-Q · filed 2026-08-07 | -$1.39M 10-Q · filed 2026-08-07 | |||
| 2025-09-30 | -$683.00K 10-Q · filed 2025-11-13 | -$348.00K derived: sum of 2 quarters · filed 2026-08-07 | -$2.20M 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $335.00K 10-Q · filed 2026-08-07 | -$1.52M 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $7.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.19M derived: sum of 2 quarters · filed 2025-11-13 | -$3.00M derived: sum of 3 quarters · filed 2025-11-13 | -$11.65M 10-K · filed 2025-03-31 | |
| 2024-09-30 | -$3.08M 10-Q · filed 2025-11-13 | -$10.26M derived: sum of 2 quarters · filed 2025-11-13 | -$18.92M 10-Q · filed 2025-11-13 | -$13.96M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$7.19M 10-Q · filed 2025-08-14 | -$15.84M 10-Q · filed 2025-08-14 | -$10.89M derived: sum of 3 quarters · filed 2025-08-14 | -$10.36M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$4.34M 10-Q · filed 2024-05-15 | -$3.70M derived: sum of 2 quarters · filed 2025-03-31 | -$3.17M derived: sum of 3 quarters · filed 2025-03-31 | -$7.18M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-12-31 | $640.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.17M derived: sum of 2 quarters · filed 2025-03-31 | -$2.84M derived: sum of 3 quarters · filed 2025-03-31 | -$10.38M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $526.00K 10-Q · filed 2024-11-14 | -$3.48M derived: sum of 2 quarters · filed 2024-11-14 | -$11.02M 10-Q · filed 2024-11-14 | -$10.44M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$4.01M 10-Q · filed 2024-08-09 | -$11.54M 10-Q · filed 2024-08-09 | -$10.97M derived: sum of 3 quarters · filed 2024-08-09 | -$11.63M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | -$7.54M 10-Q · filed 2024-05-15 | -$6.96M derived: sum of 2 quarters · filed 2024-05-15 | -$7.62M derived: sum of 3 quarters · filed 2024-05-15 | -$8.23M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$87.00K derived: sum of 2 quarters · filed 2024-03-18 | -$691.00K derived: sum of 3 quarters · filed 2024-03-18 | -$3.55M 10-K · filed 2024-03-18 | |
| 2022-09-30 | -$662.00K 10-Q · filed 2023-11-13 | -$1.27M derived: sum of 2 quarters · filed 2023-11-13 | -$4.13M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$604.00K 10-Q · filed 2023-08-11 | -$3.46M derived: sum of 2 quarters · filed 2023-08-11 | |||
| 2022-06-03 | -$3.46M 10-Q · filed 2023-08-11 | ||||
| 2022-03-31 | -$2.86M 10-Q · filed 2023-05-12 |